Catherine Alix-Panabières: Delighted and Honored to Welcome the HORIBA Team to the LCCRH Lab
Catherine Alix-Panabières, Director of the Human Rare Circulating Cells Laboratory (LCCRH) and University Professor at the University Hospital of Montpellier, shared a post on LinkedIn:
“I was delighted and honored to welcome Dr. Hitoshi Nakamura, CTO of the HORIBA Group, who traveled from Kyoto, along with Dr. Michael Bruckner, Medical Diagnostics Business Field Leader and Director of Marketing and Business Development, and Dr. Damien Isèbe, Innovation Project Manager at HORIBA France.
I had the opportunity to present part of the work we are carrying out at the Liquid Biopsy LCCRH Lab – Human Rare Circulating Cells Laboratory, Montpellier University Hospital, on Liquid Biopsy – an essential and rapidly evolving field to which I have dedicated the past 26 years.
Thanks to our expertise, we are establishing a strong Franco-Japanese collaboration in this emerging area of oncology, with the shared goal of advancing Precision Medicine for patients with solid tumors.
The strategic directions we are now taking will allow us to move forward swiftly and under the best possible conditions.
A heartfelt thank you to the entire HORIBA team for their trust and commitment.”
More posts featuring Catherine Alix-Panabières.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023